Awarded contract

NHS Framework Agreement, Branded Medicines for London and South of England

Details

Buyer
NHS England
Supplier(s)
41 suppliers
Value
GBP 601,111,261,128
Topic
Pharmaceutical products
Published
17 September 2021
Source
uk:find_a_tender

Tender description

NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab. Lot 1: CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B. CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months Lot 4: CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B. CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 2: CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche. CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 3: CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A. CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Lot 6: CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab Lot 5: CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche. CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

Timeline

  1. Award date19 August 2021
  2. Award published17 September 2021
    Current notice

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to NHS Framework Agreement, Branded Medicines for London and South of England.

Explore all open tenders

Related buyers

Buyers similar to NHS England.

View all buyers
BuyersCountValue
  1. NHS Property Services Ltd
    455
    £2.1bn
  2. UK Shared Business Services - UKSBS
    367
    £249.3m
  3. Sellafield Limited
    353
    £15.0bn
  4. Bank of England
    293
    £2.8bn
  5. Network Rail
    261
    £19.7bn
  6. Department of Health and Social Care
    252
    £892.4m
  7. Financial Conduct Authority
    243
    £509.0m
  8. Post Office Ltd
    203
    £1.0bn
  9. Nuclear Decommissioning Authority (NDA)
    140
    £895.5m
  10. Genomics England
    114
    £59.4m

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.

Try for free